To investigate 1α,25-(OH)2D3 regulation of matrix metalloproteinase-9 (MMP-9) protein expression during osteoclast formation and differentiation, receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) were administered to induce the differentiation of RAW264.7 cells into osteoclasts. The cells were incubated with different concentrations of 1α,25-(OH)2D3 during culturing, and cell proliferation was measured using the methylthiazol tetrazolium method. Osteoclast formation was confirmed using tartrate-resistant acid phosphatase (TRAP) staining and assessing bone lacunar resorption. MMP-9 protein expression levels were measured with Western blotting. We showed that 1α,25-(OH)2D3 inhibited RAW264.7 cell proliferation induced by RANKL and M-CSF, increased the numbers of TRAP-positive osteoclasts and their nuclei, enhanced osteoclast bone resorption, and promoted MMP-9 protein expression in a concentration-dependent manner. These findings indicate that 1α,25-(OH)2D3 administered at a physiological relevant concentration promoted osteoclast formation and could regulate osteoclast bone metabolism by increasing MMP-9 protein expression during osteoclast differentiation.
Introduction
As the sole cell responsible for bone resorption, the osteoclast plays a crucial role in physiological and pathological processes in bone tissue. However, osteoclasts, highly differentiated terminal cells that exist in relatively small numbers, cannot be differentiated by subculturing and have a limited survival time [4] . Thus, restricted in vitro culturing of osteoclasts has hampered in-depth study of these cells. Receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), two factors that regulate osteoclast formation, enable in vitro culturing of osteoclasts [36] . Additionally, RNAKL and M-CSF have been used to induce the differentiation of in vitro cultured spleen, peripheral blood mononuclear, and RAW264.7 cells into large populations of osteoclasts with high purity, thereby establishing a foundation for the study of osteoclast formation and activation mechanisms at the molecular level [35, 37] . Matrix metalloproteinase (MMP) belongs to the zinc-binding endopeptidase enzyme family and is essential for extracellular matrix degradation in a variety of organs including bone. In particular, high expression of MMP-9 levels by osteoclasts plays an important role in extracellular matrix degradation by this type of cell [11, 15] . Previous studies have shown that RANKL can increase MMP-9 expression in a concentration-dependent manner while addition of the MMP-9 inhibitor GM6001 inhibits RANKL-induced formation of multinucleated osteoclasts in a dose-dependent manner [11, 15, 38] . Other recent investigations have shown that osteoclast precursor cells and osteoclasts can express the vitamin D receptor (VDR) [19] . When 1α,25-(OH) 2 D 3 is present above a threshold concentration, it promotes the expression of VDR, and enhances the binding of RANK and RANKL to the osteoclast surface, thus initiating osteoclast differentiation [6] . However, it is unclear whether vitamin D can regulate MMP-9 protein expression during osteoclast formation and activation. In the present study, RANKL and M-CSF were administered in combination to induce the differentiation of osteoclast precursor RAW264.7 cells into osteoclasts as previously reported [12, 15] . Different concentrations of 1α,25-(OH) 2 D 3 were used to investigate the effect of this compound on osteoclast morphology, bone resorption, and MMP-9 protein expression levels. Results from this investigation provided insight into the mechanisms underlying vitamin D regulation of osteoclast differentiation and activation, and provided a theoretical basis for the prevention and treatment of bone metabolic diseases.
Materials and Methods

Cell culture
Murine monocytic RAW 264.7 cells were purchased from the American Type Culture Collection (USA) and cultured as previously described with slight modification [29] . Briefly, RAW264.7 cells were gently re-suspended in Dulbecco's modified Eagle medium (DMEM; Gibco, USA) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific, USA), 4 mM L-glutamine (AMRESCO, USA), 100 IU/mL penicillin (ShanDong LuKang Pharmaceutical Group, China), and 100 mg/L streptomycin (ShanDong LuKang Pharmaceutical Group). The cells were incubated at 37 o C in a humid 5% CO 2 atmosphere (Thermo). The medium was replenished after 24 h, and then the recovered cells were further cultured for 24 h. When the cells covered 80∼90% of the flask (Corning, USA) sidewall, they were detached from the flask as follows. The cell culture medium was removed, the cells were washed three times with phosphate-buffered saline (PBS), 1 mL of 0.25% trypsin (AMRESCO) was added for 1 min, the flask was tapped to loosen the cells, and the cells in one flask were transferred to four new flasks equally. After four passages, the cells were incubated with one of the following combinations of cytokines for 48 h, 5 days and 9 days: group A: RAW264. Detection of RAW264.7 cell proliferation using an methylthiazol tetrazolium (MTT) assay RAW264.7 cells were cultured, trypsinized, and centrifuged at 200 × g for 5 min at room temperature. The supernatant was discarded, the cells were re-suspended in alpha modified Eagle medium (α-MEM; Gibco) containing 10% FBS, 4 mM L-glutamine, 100 IU/mL penicillin, and 100 mg/L streptomycin, and seeded in 96-well cell-culture plates 
Detection of bone lacunar resorption
One sterile bovine cortical bone slice (50-μm thick) (Peking University First Hospital, China) was placed in each well of a 48-well plate (Corning). Next, RAW264.7 cells cultured as described above were transferred to the bone slice at a density of 1 × 10 4 cells/well. The cells were cultured with one of the cytokine combinations (groups A ∼E) for 9 days and the bone slices were then removed. The bone slices were washed three times with PBS, sonicated three times for 5 min in 0.25 M ammonium hydroxide with a KQ-250 ultrasonic cleaner (Kunshan Ultrasonic Instrument, China), and cells attached to the bone slice were removed to expose the lacunae. After being dehydrated in a graded ethanol series (v/v) of 40%, 70%, 80%, 95%, and 100%, and air-dried, the bone slices were gilded using an ion-plating apparatus SCD500 Sputter Coater (Bal-Tec, Liechtenstein) and viewed with an XL30-ESEM environmental scanning electron microscope (Philips, The Netherlands). The area of lacunar resorption was measured by JD801 image analysis (Jiangsu JEDA Science-Technology Development, China).
Detection of MMP-9 protein expression with Western blotting RAW264.7 cells were transferred to a 6-well plate (Corning) at a density of 1 × 10 6 cells/well and incubated at 5,000; Cell Signaling Technology) at room temperature for 2 h. After additional washes with TBST, antibody binding was visualized using an ECL detection kit (Thermo) according to the manufacturer's instructions and the blots were exposed to X-ray film (Eastman Kodak Company, USA). Band volume was measured by Molecular Imager Gel Doc XR System (Bio-Rad, USA) and normalized to bands corresponding to GAPDH. 
Statistical analysis
Data were analyzed with a t test using SPSS statistical software (ver. 19.0; SPSS, USA) and expressed as the mean ± standard error (SE). p values ＜ 0.05 were considered statistically significant. p values ＜ 0.01 were considered highly statistically significant.
Results
Effects of different 1α,25-(OH) 2 D 3 concentrations on RAW264.7 cell proliferation
To evaluate the effects of 1α,25-(OH) 2 D 3 on RAW264.7 cell growth, an MTT assay was performed to evaluate cell proliferation. As shown in Fig. 1 , the proliferation rate of RAW264.7 cells cultured for 48 h in the presence of RANKL and M-CSF (groups B∼E) was significantly higher (p < 0.01) than that of the control group (group A). However, the cell proliferation rate of all three groups incubated with 1α,25-(OH) 2 D 3 in addition to RANKL and M-CSF (groups C∼E) was lower than that of the group exposed to RANKL and M-CSF alone (group B; p < 0.05 for group D and p < 0.01 for group E).
Effects of 1α,25-(OH) 2 D 3 on the morphology and number of TRAP-positive osteoclasts
After 5 days of culturing, no osteoclasts were found in group A (Fig. 2A) . In contrast, TRAP-positive multinucleated osteoclasts formed in all the other groups (Figs. 2B-E) . The number of TRAP-positive multinucleated osteoclasts in group B (3.40 ± 1.14 cells/visual field) was significantly larger than that found in the control group (group A: 0 cells /visual field, p < 0.01; Fig. 3 ). The addition Vitamin D regulation of MMP-9 expression in osteoclasts 137 
Effects of 1α,25-(OH) 2 D 3 on osteoclastic MMP-9 protein expression
In the Western blot analysis, total cell protein from every group generated positive bands 92 kDa in size (Fig. 6A) . MMP-9 protein expression levels in the cells incubated with RANKL and M-CSF were significantly higher than that in the control group (p < 0.01; Fig. 6B ). MMP-9 protein expression in group C was not significantly different from that found in group B. In contrast, 1α,25 (OH) 2 D 3 at 10 -9 M and 10 -8 M induced significantly higher levels of MMP-9 protein expression than those observed in group B (p < 0.05 and < 0.01, respectively; Fig. 6B ).
Discussion
Vitamin D and its active metabolites are important regulators of calcium and phosphorus metabolism in animals, and have an important impact on bone formation and structure. 1α,25-(OH) 2 D 3 , the primary active form of vitamin D, increases intestinal calcium and phosphorus absorption, thus promoting bone calcification. This compound also acts directly on bone cells through the VDR or independently [1, 20, 33] .
Effects of 1α,25-(OH) 2 D 3 on RAW264.7 cell proliferation
Osteoclasts are directly or indirectly regulated by a variety of cytokines, and appear as multinucleated cells after proliferation, fusion, and differentiation. RANKL and M-CSF are important stimulatory factors that influence osteoclast formation and differentiation. Competitive binding between RANKL and RANK on the cell membrane of osteoclast precursors induces osteoclast differentiation. On the other hand, M-CSF promotes osteoclast formation and proliferation primarily through binding to the c-Fms receptor on the osteoclast precursor cell surface [5, 13] . In the present study, RAW264.7 cells were incubated with RANKL and M-CSF along with different concentrations of 1α,25-(OH) 2 [21] . Recently, it was shown that 1α,25-(OH) 2 D 3 can increase the number of osteoclasts derived from bone marrow stem cells through RANKL and M-CSF in vitro [18, 22] . The primary mechanism involved an increase in the RANKL : osteoprotegerin ratio in osteoblasts compared to bone marrow stromal cells that indirectly regulates osteoclast formation and differentiation [3, 28] . M-CSF plays an important role in the induction of osteoclast proliferation [9, 10, 30] . In the present study, TRAP-positive multinucleated osteoclasts were observed after 5 days of incubating RAW264.7 cells in culture medium containing RANKL and M-CSF. The addition of 1α,25-(OH) 2 D 3 to this medium resulted in a dose-dependent increase in the number of osteoclasts that reached a maximum with 10 -8 M. This result was similar to data from a study by Vincent et al. [31] , and concurs with the finding that 1α,25-(OH) 2 D 3 inhibited RAW264.7 cell proliferation in a dose-dependent manner. Furthermore, 1α,25-(OH) 2 D 3 can inhibit the proliferation of various cells, including human periodontal ligament cells [27] and primary osteoblasts [2] , while encouraging cell differentiation [23, 34] . After 9 days of incubation in induction medium, significant resorption lacunae were formed on bovine cortical bone slices. Lacunae formation was increased in a dose-dependent manner by 1α,25-(OH) 2 D 3 with the most extensive effect observed with 10 -8 M. These results are consistent with those reported by Naruse et al. [22, 26] , and confirmed that radial bone mineral density (BMD) decreased across increasing concentrations of 1, 25(OH) 2 D 3 [7] .
Regulation of MMP-9 protein expression by 1α,25-(OH) 2 D 3 during osteoclast differentiation MMP-9 was first discovered in the osteoclast lineage during mouse development by Repone et al. [25] . This proteolytic enzyme is highly expressed in osteoclasts and important for extracellular matrix degradation during bone resorption as well as bone remodeling. A number of studies have been conducted to elucidate the regulatory mechanism governing osteoclastic MMP-9 protein expression during bone absorption [14, 16, 32] . RAW264.7 cells are osteoclast precursors and can express phenotype marker genes characteristic of mature osteoclasts [8] . It has been shown that the osteolytic functions of osteoclasts are mainly facilitated by the secretion of carbonic anhydrase II, MMP-9, and other enzymes into closed cavities formed on the bone surface [24] . In the present study, different concentrations of 1α,25-(OH) 2 D 3 were added to induce the differentiation of RAW264.7 cells into osteoclasts after incubation with RANKL and M-CSF. The capacity of 1α,25-(OH) 2 D 3 to enhance monocyte fusion for the formation of osteoclasts was increased in a dose-dependent manner. At 10 -8 M, 1α,25-(OH) 2 D 3 significantly increased the number of osteoclasts, the bone resorption capacity of the osteoclasts, and MMP-9 protein expression. These observations were similar to those reported by Kido [17] . In summary, 1α,25-(OH) 2 D 3 was found to increase the number of osteoclasts cultured in vitro in a dose-dependent manner. MMP-9 protein expression was also elevated and bone resorption was enhanced. Our findings demonstrate that 1α,25-(OH) 2 D 3 plays a crucial role in bone metabolism.
